Caricamento...
Advances in the Management of Treatment-Resistant Depression
Treatment-resistant depression (TRD) is a prevalent, disabling, and costly condition affecting 1%–4% of the U.S. population. Current approaches to managing TRD include medication augmentation (with lithium, thyroid hormone, buspirone, atypical antipsychotics, or various antidepressant medications),...
Salvato in:
| Pubblicato in: | Focus (Am Psychiatr Publ) |
|---|---|
| Autore principale: | |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2010
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4423609/ https://ncbi.nlm.nih.gov/pubmed/25960694 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1176/foc.8.4.foc488 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|